Seek Returns

LLY vs. META: Eli Lilly vs. Meta Platforms Stock Comparison

How do Eli Lilly (LLY) and Meta Platforms (META) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Eli Lilly (LLY) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas Meta Platforms (META) belongs to Communication Services (Media & Entertainment) — their GICS classifications point to very different parts of the market.

Company profile comparison for Eli Lilly (LLY) and Meta Platforms (META)
Profile ItemLLYMETA
NameEli Lilly and CompanyMeta Platforms Inc Class A
Country/RegionUnited StatesUnited States
GICS SectorHealth CareCommunication Services
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesMedia & Entertainment
GICS IndustryPharmaceuticalsInteractive Media & Services
GICS Sub-IndustryPharmaceuticalsInteractive Media & Services
Market Capitalization1,057.35 billion USD1,508.38 billion USD
CurrencyUSDUSD
ExchangeNYSENasdaq
Listing DateJune 1, 1972May 18, 2012
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

LLY
META
GSPC
Loading price history…
Eli Lilly (LLY) vs. Meta Platforms (META), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Eli Lilly (LLY) and Meta Platforms (META). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Eli Lilly (LLY) and Meta Platforms (META). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Eli Lilly (LLY) and Meta Platforms (META)
MetricLLYMETA
Total Return (1Y)86.33%-22.02%
Total Return (3Y, Annualized)38.69%23.57%
Total Return (5Y, Annualized)36.38%10.44%

Risk Profile

Drawdown History

LLY
META
GSPC
Loading price history…
Eli Lilly (LLY) vs. Meta Platforms (META), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Eli Lilly (LLY) and Meta Platforms (META). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Eli Lilly (LLY) and Meta Platforms (META)
MetricLLYMETA
Volatility (1Y, Annualized)35.74%38.34%
Beta (5Y)0.501.25
Max Drawdown (5Y)-34.48%-76.74%
Avg. Volume (3M)3.06M18.00M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
LLY and META are plotted by 1-year volatility (risk) and 1-year return. Each dashed Capital Allocation Line uses that stock's own industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Eli Lilly (LLY) and Meta Platforms (META)
MetricLLYMETA
Sharpe Ratio (1Y)2.30-0.68
Sortino Ratio (1Y)4.03-0.95

Profitability

ROE (TTM)

Both Eli Lilly (LLY) at 102.29% and Meta Platforms (META) at 29.85% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

102.29%

LLY
102.29%
Max
102.29%
Q3
2.88%
Median
-33.17%
Q1
-64.41%
Min
-157.61%

META

Media & Entertainment industry group

29.85%

Max
48.68%
META
29.85%
Q3
16.74%
Median
6.46%
Q1
-5.13%
Min
-37.13%
Loading chart…
Eli Lilly (LLY) vs. Meta Platforms (META): A comparison of their ROE against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Net Margin (TTM)

Eli Lilly (LLY) at 33.53% keeps the most of each sales dollar — above its industry’s net margin range — and Meta Platforms (META) at 29.84% also retains a top-quartile share.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

33.53%

LLY
33.53%
Max
11.21%
Q3
2.65%
Median
0.00%
Q1
-4.14%
Min
-13.58%

META

Media & Entertainment industry group

29.84%

Max
30.77%
META
29.84%
Q3
9.84%
Median
3.58%
Q1
-4.22%
Min
-24.17%
Loading chart…
Eli Lilly (LLY) vs. Meta Platforms (META): A comparison of their net margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Operating Margin (TTM)

Both Eli Lilly (LLY) at 54.22% and Meta Platforms (META) at 34.83% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

54.22%

Max
94.41%
LLY
54.22%
Q3
8.92%
Median
0.00%
Q1
-119.39%
Min
-309.54%

META

Media & Entertainment industry group

34.83%

Max
41.37%
META
34.83%
Q3
17.93%
Median
9.02%
Q1
-1.89%
Min
-27.39%
Loading chart…
Eli Lilly (LLY) vs. Meta Platforms (META): A comparison of their operating margin against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Profitability Metrics

Profitability metrics for Eli Lilly (LLY) and Meta Platforms (META)
MetricLLYMETA
ROE (TTM)102.29%29.85%
ROA (TTM)20.36%14.59%
Net Margin (TTM)33.53%29.84%
Operating Margin (TTM)54.22%34.83%
Gross Margin (TTM)83.40%81.75%

Growth

Revenue Growth

Meta Platforms (META) at 22.17% sits in the top revenue growth quartile, while Eli Lilly (LLY) at 44.70% is closer to the peer norm — faster top-line expansion for META.

Loading chart…
Eli Lilly (LLY) vs. Meta Platforms (META): A comparison of their Revenue Growth across different time periods.

EPS Growth

Eli Lilly (LLY) at 95.99% sits in the top EPS growth quartile, while Meta Platforms (META) at -1.55% is closer to the peer norm — faster per-share earnings growth for LLY.

Loading chart…
Eli Lilly (LLY) vs. Meta Platforms (META): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Eli Lilly (LLY) and Meta Platforms (META)
MetricLLYMETA
Revenue Growth (YoY)44.70%22.17%
Revenue Growth (3Y CAGR)31.69%19.89%
EPS Growth (YoY)95.99%-1.55%
EPS Growth (3Y CAGR)51.71%39.84%

Financial Strength

Current Ratio (MRQ)

Meta Platforms (META) at 2.23 keeps current ratio within its industry’s typical mid-range, while Eli Lilly (LLY) at 1.36 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for LLY.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.36

Max
26.16
Q3
12.25
Median
5.88
Q1
2.81
LLY
1.36
Min
0.55

META

Media & Entertainment industry group

2.23

Max
4.86
Q3
2.72
META
2.23
Median
1.56
Q1
0.87
Min
0.09
Loading chart…
Eli Lilly (LLY) vs. Meta Platforms (META): A comparison of their current ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Debt / Equity (MRQ)

Meta Platforms (META) at 0.43 carries an industry-typical debt-to-equity mix, while Eli Lilly (LLY) at 1.62 uses more debt funding than most peers.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.62

Max
1.64
LLY
1.62
Q3
0.68
Median
0.16
Q1
0.02
Min
0.00

META

Media & Entertainment industry group

0.43

Max
2.58
Q3
1.26
Median
0.52
META
0.43
Q1
0.17
Min
0.00
Loading chart…
Eli Lilly (LLY) vs. Meta Platforms (META): A comparison of their debt-to-equity ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Financial Strength Metrics

Financial strength metrics for Eli Lilly (LLY) and Meta Platforms (META)
MetricLLYMETA
Current Ratio (MRQ)1.362.23
Debt / Equity (MRQ)1.620.43
Net Debt / EBITDA1.100.20

Dividends

Dividend Yield (TTM)

Both Eli Lilly (LLY) at 0.54% and Meta Platforms (META) at 0.36% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.54%

LLY
0.54%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

META

Media & Entertainment industry group

0.36%

META
0.36%
Max
0.24%
Q3
0.12%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Eli Lilly (LLY) vs. Meta Platforms (META): A comparison of their dividend yield against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Dividend Payout Ratio (TTM)

Meta Platforms (META) at 7.91% keeps its payout in the industry’s typical band, while Eli Lilly (LLY) at 21.69% pays out more than any of its peers — the most stretched cover in its group.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

21.69%

LLY
21.69%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

META

Media & Entertainment industry group

7.91%

Max
34.19%
Q3
14.58%
META
7.91%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Eli Lilly (LLY) vs. Meta Platforms (META): A comparison of their payout ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Dividend Metrics

Dividend metrics for Eli Lilly (LLY) and Meta Platforms (META)
MetricLLYMETA
Dividend Yield (TTM)0.54%0.36%
Dividend Payout Ratio (TTM)21.69%7.91%

Valuation

P/E Ratio (TTM)

Both Eli Lilly (LLY) at 40.00 and Meta Platforms (META) at 22.23 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

40.00

Max
84.14
Q3
43.16
LLY
40.00
Median
28.60
Q1
15.80
Min
2.32

META

Media & Entertainment industry group

22.23

Max
74.32
Q3
36.91
META
22.23
Median
20.53
Q1
11.74
Min
1.83
Loading chart…
Eli Lilly (LLY) vs. Meta Platforms (META): A comparison of their P/E ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

P/S Ratio (TTM)

Eli Lilly (LLY) at 13.27 is priced about in line with its industry on P/S ratio, while Meta Platforms (META) at 6.61 sits in the pricier quartile — META costs more per dollar of sales.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.27

Max
70.39
Q3
30.57
LLY
13.27
Median
7.62
Q1
3.50
Min
0.01

META

Media & Entertainment industry group

6.61

Max
6.92
META
6.61
Q3
3.80
Median
1.58
Q1
0.67
Min
0.00
Loading chart…
Eli Lilly (LLY) vs. Meta Platforms (META): A comparison of their P/S ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

P/B Ratio (MRQ)

Both look rich against book: Meta Platforms (META) at 6.17 sits in the upper P/B ratio quartile, and Eli Lilly (LLY) at 33.96 prices even higher, above its industry range.

LLY

Pharmaceuticals, Biotechnology & Life Sciences industry group

33.96

LLY
33.96
Max
17.22
Q3
8.05
Median
3.87
Q1
1.75
Min
-7.69

META

Media & Entertainment industry group

6.17

Max
13.02
META
6.17
Q3
5.78
Median
2.08
Q1
0.83
Min
-5.00
Loading chart…
Eli Lilly (LLY) vs. Meta Platforms (META): A comparison of their P/B ratio against their respective Pharmaceuticals, Biotechnology & Life Sciences and Media & Entertainment industry group benchmarks.

Valuation Metrics

Valuation metrics for Eli Lilly (LLY) and Meta Platforms (META)
MetricLLYMETA
P/E Ratio (TTM)40.0022.23
P/S Ratio (TTM)13.276.61
P/B Ratio (MRQ)33.966.17
Free Cash Flow Yield (TTM)1.05%1.43%